<DOC>
	<DOCNO>NCT01754233</DOCNO>
	<brief_summary>The purpose study assess treatment facial dermal epidermal pigment lesion use 755nm Alexandrite laser .</brief_summary>
	<brief_title>Evaluation 755nm Alexandrite Treatment Epidermal Dermal Pigmented Lesions</brief_title>
	<detailed_description />
	<criteria>1 . Is healthy male female 18 85 year old 2 . Has unwanted dermal and/or epidermal pigment lesion desire skin tone wish undergo laser treatment . 3 . Is willing consent participate study . 4 . Is willing comply requirement study include photograph , follow post treatment care attend treatment follow visit . 5 . Has Fitzpatrick skin type III IV . 1 . The subject female pregnant , pregnant within last 3 month , currently breast feed plan pregnancy study period . 2 . The subject hypersensitive light exposure OR take photo sensitized medication . 3 . The subject active localize systemic infection 4 . The subject condition , investigator 's opinion , would make unsafe subject participate research study . 5 . The subject currently enrol investigational drug device trial , receive investigational drug treat investigational device within 3 month prior enter study . 6 . The subject use Accutane within 6 month prior enrollment . 7 . The subject need expose artificial tanning device excessive sunlight trial . 8 . The subject prior treatment parenteral gold therapy ( gold sodium thiomalate ) . 9 . The subject prior treatment laser device treatment area within 3 month . 10 . The subject history keloid hypertrophic scar . 11 . The subject evidence compromise wound heal . 12 . The subject history squamous cell carcinoma melanoma 13 . The subject history immunosuppression/immune deficiency disorder ( include HIV infection AIDS ) use immunosuppressive medication . 14 . Is allergic topical lidocaine topical steroid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>